Market revenue in 2023 | USD 137.4 million |
Market revenue in 2030 | USD 167.1 million |
Growth rate | 2.8% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | Home Care |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Home Care |
Key market players worldwide | Becton Dickinson & Co, BioMerieux SA, Bio-Rad Laboratories Inc, Abbott Laboratories, Agilent Technologies Inc, Danaher Corp, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Roche Holding AG, Siemens Healthineers AG ADR, Sysmex Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 47.23% in 2023. Horizon Databook has segmented the South Africa molecular diagnostics market based on hospitals, outpatient facilities, home care covering the revenue growth of each sub-segment from 2018 to 2030.
Government of South Africa made improvements in basic healthcare reforms by providing free primary healthcare and diagnostic services to children & pregnant women. The government also collaborated with the UN to improve healthcare measures toward decreasing mortality rates and increasing life expectancy.
Several multinational companies, such as F. Hoffmann-La Roche AG, are showing interest in the South Africa market, forming joint ventures with local companies, such as The Southern African Laboratory Diagnostics Association (SALDA) a body that represents laboratory medicine in the country, that distributes IVD tests.
Hence, owing to the aforementioned factors, the molecular diagnostics market in South Africa is expected to witness significant growth during the forecast period. As South Africa has one of the highest prevalence of Human Immunodeficiency Viruses (HIV), HIV viral load testing is performed on a large scale under the National Priority Program, established in 2010.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into South Africa molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account